TY - CHAP M1 - Book, Section TI - Atrial Fibrillation MTM Data Set A1 - Anderson, Katherine Vogel A1 - Honaker, Sarah E. A2 - Whalen, Karen A2 - Hardin, Heather C. Y1 - 2018 N1 - T2 - Medication Therapy Management: A Comprehensive Approach, 2e AB - KEY POINTSAtrial fibrillation (AF) is a common supraventricular tachycardia.The management of AF centers on rate and/or rhythm control and prevention of stroke.Risk of thromboembolic stroke must be assessed in every patient with AF so that appropriate preventive measures can be implemented. Medication therapy management (MTM) providers should be familiar with risk assessment tools and strategies for stroke prevention.Medications used for stroke prevention, rate control, and rhythm control in AF have many important drug interactions (eg, warfarin, amiodarone). MTM providers should be vigilant for drug interactions in patients with AF and, when possible, recommend alternative therapies for other disorders that minimize the risk of significant interactions. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1150198464 ER -